Abstract

Patients' Preference for a Specific Anti-Tumor Necrosis Factor Agent: Korea versus Western.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call